CTOR

Citius Oncology
CTOR

6 hedge funds and large institutions have $97.7K invested in Citius Oncology in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 5

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$23.2K
2
+$7.34K

Top Sellers

1
-$78K
2
-$26.1K
3
-$24.3K
4
Renaissance Technologies
Renaissance Technologies
New York
-$12.9K
5
Osaic Holdings
Osaic Holdings
Arizona
-$4.76K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$46.3K
IA
2
IFP Advisors
Florida
$20.7K
Geode Capital Management
3
Geode Capital Management
Massachusetts
$19.1K
YCM
4
Yakira Capital Management
Connecticut
$11.2K
Osaic Holdings
5
Osaic Holdings
Arizona
$325
Bank of America
6
Bank of America
North Carolina
$149
HF
7
HRT Financial
New York
–
Citadel Advisors
8
Citadel Advisors
Florida
–
XT
9
XTX Topco
Cayman Islands
–
Renaissance Technologies
10
Renaissance Technologies
New York
–
TRCT
11
Tower Research Capital (TRC)
New York
–